The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer

Metformin, a drug approved for diabetes type II treatment, has been associated with a reduction in the incidence of breast cancer and metastasis and increased survival in diabetic breast cancer patients. High levels of miR-26a expression have been proposed as one of the possible mechanisms for this...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabello, Paula, Pineda, Begoña, Tormo, Eduardo, Lluch, Ana, Eroles, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000695/
https://www.ncbi.nlm.nih.gov/pubmed/27517917
http://dx.doi.org/10.3390/ijms17081298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000695/
https://www.ncbi.nlm.nih.gov/pubmed/27517917
http://dx.doi.org/10.3390/ijms17081298

Ejemplares similares